The Sackler family wants protection from opioid lawsuits. Will the Supreme Court grant it?
by Ariana Baio
Dec 05, 2023
3 minutes
In the mid-late 1990s, Purdue Pharma began manufacturing, and heavily marketing, an opioid pill that has quickly become a thorn in the side of the world: OxyContin.
The implications of the pill, which is widely believed to have heavily contributed to, if not sparked, the opioid epidemic, is now making its way to the Supreme Court in a case that, at first, appears as another bankruptcy case.
In justices are being asked to decide if a reorganisation plan created by Purdue Pharmaceuticals under their Chapter 11 claim, can allow, to be granted immunity from civil liability even though the Sacklers have not declared bankruptcy themselves.
You’re reading a preview, subscribe to read more.
Start your free 30 days